AJ
₹3,319.70
-80.30(-2.36%)
AJANTPHARM₹3,319.70-2.36%
71/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %AJANTPHARM financial summary
For Mar 2026, Ajanta Pharma Limited reported revenue of ₹4,846 crore, which grew 12.1% from the previous year. Net profit was ₹947 crore, which grew 3.3% year on year, on an operating margin of 25%. Earnings per share came in at ₹75.78. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹4,846 crore |
|---|---|
| Net profit | ₹947 crore |
| Operating margin | 25% |
| EPS | ₹75.78 |